AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

M&A — AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports  CNBC

Read the original at M&A ↗

Auto-published by the finit.news Events monitor from M&A; summarized by AI and may contain errors — verify against the primary source. August 2, 2026.